Over the years I became more and more intrigued by how many diseases remain uncured in today’s world. For me a personal success would be to help Moderna push the frontier of this technology from proof of concept animal studies to bringing these products to patients in clinical trials. And I would love to see theses products, 5-10 years out curing previously uncured diseases.
Graduated on 2013
Harvard Business School
United States of America
Senior Director, Corporate Development, Moderna Therapeutics